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Abstract.  The Plasmodium falciparum gene encoding 
erythrocyte binding antigen-175  (EBA-175),  a putative 
receptor for red cell invasion (Camus,  D., and T. J. 
Hadley.  1985.  Science  (Wash. DC).  230:553-556.),  has 
been isolated and characterized.  DNA sequencing 
demonstrated a  single open reading frame encoding a 
translation  product of 1,435  amino acid residues.  Pep- 
tides corresponding to regions on the deduced amino 
acid sequence predicted to be B cell epitopes were as- 
sessed for immunogenicity.  Immunization  of mice and 
rabbits with EBA-peptide 4, a  synthetic peptide en- 
compassing amino acid residues  1,062-1,103,  produced 
antibodies that recognized P. falciparum merozoites in 
an indirect fluorescent antibody assay.  When compared 
to sera from rabbits immunized with the same adju- 
vant and carrier protein,  sera from rabbits immunized 
with EBA-peptide 4  inhibited merozoite invasion of 
erythrocytes in vitro by 80%  at a  1:5 dilution.  Fur- 
thermore,  these sera inhibited the binding of purified, 
authentic EBA-175 to erythrocytes, suggesting that 
their activity in inhibiting merozoite invasion of 
erythrocytes is mediated by blocking the binding of 
EBA-175 to erythrocytes. Since the nucleotide se- 
quence of EBA-peptide 4  is conserved among seven 
strains of P. falciparum from throughout the world 
(Sim,  B. K.  L.  1990.  Mol.  Biochem.  Parasitol. 
41:293-296.),  these data identify a region of the pro- 
tein that should be a focus of vaccine development 
efforts. 
M 
ALARIA disease,  which is estimated to directly ac- 
count for more than one million deaths per year 
worldwide  (Sturchler,  1989),  is  caused  by  the 
erythrocytic stages of parasites of the genus  Plasmodium. 
Conventional  approaches to control malaria  using  insecti- 
cides and antimalarial  drugs have met with major problems 
due  to  the  resurgence  of  resistant  strains  of  both  the 
mosquito vector and the parasite.  In recent years there have 
been considerable efforts to develop vaccines against malaria 
(Miller et al.,  1986).  Within the human host, the malarial 
parasite is intracellular  for the major part of its life cycle. Ex- 
ceptions to this are the sporozoite stage, which is introduced 
by the mosquito vector and invades liver hepatocytes; and 
the merozoite stage,  which invades erythrocytes. Both the 
sporozoite and the merozoite are briefly extracellular,  and 
must invade their respective cells within minutes to ensure 
further  development.  Attempts  at achieving  protection to 
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this parasite have focused on trying to attain immunity to the 
extracellular  stages because it is during this short period that 
the parasite should be most vulnerable to immune attack. 
One approach to malaria  vaccine development is to induce 
immune  responses  that  prevent  interaction  of merozoite 
receptors with complementary erythrocyte ligands. 
Merozoite  recognition  and  invasion  of erythrocytes  is 
probably a multi-step  process and depends on the ability of 
the merozoite to recognize ligands on the erythrocyte mem- 
brane (Miller et al.,  1977; Pasvol and Jungery,  1984; Per- 
kins,  1984; Okoye and Bennet,  1985;  Hadley and Miller, 
1988). Several studies of P. falciparum merozoite-erythro- 
cyte interaction have identified erythrocyte membrane glyco- 
phorins  and  sialic  acid as ligands  important  for invasion 
(Miller et al., 1977; Pasvol et al., 1982; Pasvol and Jungery, 
1984; Hadley et al.,  1988). A potential  sialic acid binding 
antigen is the 175-kD erythrocyte binding antigen (EBA-175) 
(Camus  and  Hadley,  1985).  This  antigen  was isolated by 
using intact erythrocytes as an affinity substrate.  EBA-175 
binds to erythrocytes susceptible to invasion,  with a clear 
correlation between invasion  efficiency and the ability for 
EBA-175 to bind (Camus and Hadley,  1985; Orlandi  et al., 
1990). Evidence obtained so far suggests that EBA-175 rec- 
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of the erythrocyte glycophorins (Camus and Hadley, 1985; 
Orlandi et al., in preparation). EBA-175 also binds to mero- 
zoites. EBA-175 is distinct from the 155-kD antigen (Camus 
and Hadley, 1985) and the merozoite surface antigen Pf200 
(gp195)  (Orlandi et al.,  1990).  On the basis of the binding 
specificities and binding to merozoites, EBA-175 was pro- 
posed to be a parasite receptor acting as a "bridge" between 
the merozoite and the erythrocyte. 
Since EBA-175 was thought to be involved in the attach- 
ment of the merozoite to the erythrocyte, our approach was 
to isolate the gene encoding EBA-175, and then determine 
whether antibodies against B cell epitopes on the protein en- 
coded by this gene could interfere with merozoite invasion 
of erythrocytes. We present data on the characterization of 
the gene encoding EBA-175, and show that antibodies against 
a synthetic peptide comprising amino acid residues 1,062- 
1,103 (EBA-peptide 4) block the binding of EBA-175 to eryth- 
rocytes and also inhibit merozoite invasion of erythrocytes 
in vitro. 
Materials and Methods 
Cultivation of  P. falciparum and Isolation of  EBA-175 
Cloned Camp strain (Malaysia)  P, falciparum were cultured in vitro and 
synchronized using conventional protocols (Vernes et al.,  1984). Affinity- 
purified EBA-175 was prepared by using human erythrocytes as an affinity 
substrate to bind EBA-175 harvested from culture supernatants, and then 
eluted offwith a nigh salt buffer (Haynes et al., 1988; Orlandi et al., 1990). 
Specific Antibodies against EBA-175 
Polyclonal monospecific antibodies against EBA-175 were isolated from the 
sera of immune Aotus monkeys  immunized against the Camp  strain of 
P. falciparum by affinity purification against EBA-175 adsorbed to nitrocel- 
lulose (Orlandi et al.,  1990). 
Immunoblotting 
Antigens were fractionated by SDS-PAGE (Towbin et al.,  1979),  and im- 
munoblotted  as described (Ham et al., 1984). Diluent for antisera was TBS- 
0.05 % Tween 20. Reactions were detected with alkaline phosphatase-linked 
anti-Aotus  IgG (gift from Dr.  A. Thomas,  Department of Immunology, 
Walter Reed Army Institute of Research,  Washington,  D.C.) or anti-mouse 
IgG (Promega Biotec,  Madison, Vii) and developed  with 50 mg/ml nitro 
blue tetrazolium and 50 mg/ml 5-bromo-4-chloro-3-iudolylphosphate  (Pro- 
mega Biotec)  by method of Blake et al. 0984). 
Library Screening 
Initially, affinity-purified monospecific antibodies to EBA-175 were used to 
screen a Camp strain genomic mung bean nuelease expression library in 
lambda gtll  (Lyon,  et  al.,  1986).  Nitrocellulose filters  (Scnieicher & 
SchueIl, Inc., Keene, NH) were saturated with I0 ram isopropyl-beta-thio- 
D-galactopyranoside  (IPTG) (Sigma Chemical Company,  St. Louis, MO), 
and duplicate plaque lifts of ~ 300,000 plaques plated at a density of 30,000 
plaques per 150-ram Petri dish were made (Young and Davis,  1983). The 
filters were blocked in 0.3%  Tween 20 in 50 mM Tris,  pH 8.0, 150 mM 
NaCI TBS for 1 h at room temperature, and rinsed in 0.05% Tween 20 in 
TBS before air drying. The filters were next rehydrated in 0.05 % Tween 20 
in TBS for 20 rain and probed with affinity-purified monospecific antibodies 
to EBA-175 (Oflandi et al., 1990), overnight at 4°C. These filters were then 
rinsed in 0.05% Tween 20 in TBS, probed with alkaline phosphatase-con- 
jugated anti-ADtuS IgG for 90 rain and developed  following the same pro- 
tocols as in immunoblotting. One positive plaque EBAI.8/YI090 with a 1.8- 
kb insert was isolated and plaque purified through four cycles of subcloning 
and plating until all plaques tested positive. 
Gene Isolation 
The 1.8-kb insert was labeled by nick translation (Nick Translation System, 
Bethesda Research Laboratories, Gaithersburg, MD) with 32P-alpha-dTTp 
(3,000 Ci/mmol; New England Nuclear, Boston, MA) and used as a probe 
to identify a single 5.5-kb fragment on a restriction endonuclease Xba I 
genomic Southern blot (Southern, 1975).  To isolate this 5.5-kb fragment 
which appeared to contain further unidentified EBA-175 gene sequences,  a 
size selected (4.4-6.6  kb) Xba I  genomic library.was constructed and 
screened with labeled 1.8-kb fragment. A 200-bp sequence from the 5' end 
of this 5.5-kb fragment thus isolated,  was amplified using oligonucleotide 
primers by the polymeraso chain reaction (Saiki et al., 1988), labeled, and 
used as a probe to isolate a clone (EBA2.5/YI090) containing a 2.5-kb frag- 
ment from the initial lambda gtll library.  Subsequent to this, a 250-bp se- 
quence was amplified from the 5' end of the 2.5-kb fragment, labeled, and 
used as a probe to identify a 3.5-kb fragment on an Xba I genomic Southern 
blot. To isolate this 3.5-kb Xba I fragment which appeared  to contain the 
rest of the gene encoding EBA-175, another size-selected (2.3-4.4 kb) Xba I 
genomic library was constructed and screened using the same 250-bp frag- 
ment as a probe. 
Expression and Analysis of  Product 
Purified DNA from EBA1.8/Y1090 was transfected into the expression host 
cell Escherichia coil Y1089 and expressed by standard procedures as a poly- 
peptide fused to beta-galactosidase (Young and Davis,  1983).  The lysate 
from clone 1.8/Y1089, before and after induction, was analyzed in duplicate 
by SDS-PAGE and immunoblotted  (Ham et al., 1984). One blot was probed 
with affinity-purified  monospecific  antibodies to EBA-175, and the other 
with antibodies against beta-galactosidase (gift from Dr. D. Lanar). The ex- 
pressed protein of clone 1.8/Y1089 was used to affinity purify antibodies as 
previously  described (Orlandi et al., 1990) from immune Aotus monkeys. 
These afffinity-purified antibodies were then used to probe blots of purified 
authentic EBA-175. Similarly,  nitrocellulose  filters saturated with 10 mM 
IPTG were used to make lifts of confluent plates (Lyon et al., 1986) of phage 
EBAI.8fI090. Affinity purification of A_otus monkey antibodies specific for 
the expressed protein on these filters was performed as described (Orlandi 
et al., 1990) and these antibodies were used to probe preparations of authen- 
tic EBA-175, as mentioned above. 
Sequencing 
All clones to be analyzed were subcloned into the bidirectional sequencing 
vector pGEM4Z (Pronmga Biotec).  The clones containing the 1.8- and 5.5- 
kb  inserts,  respectively,  were  prepared  for  sequencing by constructing 
progressive exonuclease  HI deletion subclones from the 3' end with the 
erase-a-base kit (Promega Biotec), following the manufacturer's specifica- 
tions. Sequencing of the entire 1.8-kb insert as well as relevant parts of the 
5.5-, 2.5-, and 3.5-kb inserts was performed with a modified T7 polymerase 
(Sequenase;  United States Biochemical Corp., Cleveland,  OH).  Sequenc- 
ing was performed in both orientations for all fragments analyzed. 
Sequence Analysis 
The DNA and deduced amino acid sequence of EBA-175 was compared to 
the Swiss  Protein Data bank (release  10.0) through BIONET using the 
FASTA program (Pearson and Lipman, 1988); as well as to the GENEMBL 
data base using the GCG program (Devereux et al., 1984). Antigenic deter- 
minants were predicted for the deduced amino acid sequence of EBA-175 
using an average group length of six amino acid residues to include the areas 
of nighest hydropnilicity  indices (Hopp and Woods,  1981). Studies of the 
electrical charge as a function of the pH was analyzed using the PCGENE 
software program CHARGEPRO. 
Antisera 
Synthetic peptides  with an added  NH2-terminal  cysteine  residue  were 
generated on a protein synthesizer (model 430A; Applied Biosystems, Inc., 
Foster City, CA).  Analytical HPLC and quantitative amino acid analyses 
confirmed identity and purity of the products.  Peptides  were conjugated 
separately  with glutaraldehyde  (W'mz et al., 1987) to the carrier molecule 
keyhole limpet hemocyanin (KLH) 1 and dialyzed with 2  ×  2 L PBS before 
use.  BALB/c mice and rabbits were injected subcutaneously with an esti- 
mated  100 and  150 ~g each of peptide in Freund's complete adjuvant, 
respectively. These animals were boosted twice at 3-wk intervals with 100 
~,g of peptide in Freund's incomplete adjuvant.  Antibodies to unconjugated 
peptides were measured by ELISA  OV~rtz et al.,  1989). 
1. Abbreviation  used in this paper: KLH, keyhole limpet hemocyanin. 
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Immunoprecipitation  of unlabeled or radiolabeled culture supernatants con- 
taining EBA-175 were performed with antibodies against EBA-peptide 4 as 
previously described (Lyon et al., 1987). After SDS-PAGE, precipitated an- 
tigens were detected either by immunoblot analysis or fluorography  with 
ENaHANCE (New England Nuclear,  Boston, MA). 
lmmunofluorescence Assays 
Reactivity of sera from immunized animals with P. falciparum blood stage 
parasites was determined by a two-color immunofluorescence  assay as pre- 
viously described (Klotz et al.,  1989).  mAb 3B10.1 (Lyon et al.,  1987) 
against the merozoite surface  antigen gp195 of blood stage P. falciparum 
parasites was used as a control. 
Blocking of  Erythrocyte Binding Assay 
Serum from rabbits immunized with three doses of EBA-peptide 4 con- 
jugated to KLH or rabbits immunized with three doses of KLH alone were 
preabsorbed twice  on  human erytlu'oc~es by  incubating  1 vol packed 
erythrocytes to 2 vol of serum, and gently rocking at 4"C for I h. Sera were 
heat inactivated at 56°C for 30 rain before use.  Reaction mixtures of 100 
/,1 final volume included 50/~1 of EBA-175 containing supernatants from 
3H-isoleucine-labeled cultures (Camus and Hadley,  1985; Odandi et al., 
1990), 0, 5, or 20/~1 sera from rabbits that bad been immunized with EBA- 
peptide 4 conjugated to KLH, or with 0, 5, or 20/~1 sera from rabbits that 
had been immunized with KLH alone, and culture medium sufficient to 
bring the final volume to 100/~1. After incubation overnight  at room temper- 
ature, the reaction mixtures were incubated for 30 rain with 100 t~l of  packed 
erythrocytes and eluates were obtained as described (Orlandi et al., 1990). 
Eluates were separated by SDS-PAGE and detected by fluorography. Quan- 
titation of ERA-175 binding in the presence of anti-EBA peptide 4 sera was 
performed by scanning laser densitometry (LKB 2022 Ultrascan Laser den- 
sitometer) of the resulting autoradiograph, and expressed  as a percentage 
of KLH-centrol samples in which labeled culture supernatants without im- 
mune serum were incubated with erythrocytes. 
Inhibition Assay 
The inhibition of merozoite invasion assay was a modification of that previ- 
ously  described  (Chulay  et  al.,  1981). Percoll-purified,  synchronized 
(Vernes et al.,  1984) Camp strain sehizonts (5  x  105) and fresh erythro- 
cytes (5 x  106) were cultured with the respective erythroeyte-preadsorbed, 
heat-inactivated  sera in triplicate 100-/,1 samples.  After 18 h, thin blood 
films  were prepared and the number of infected  erythrocytes per  1,000 
erythrocytes determined. Percentage inhibition was calculated as follows: 
Control -  Test  % inhibition =  x  100 
Control 
"Control" is the number of parasites which invaded  1,000 erythrocytes in 
the presence of serum from rabbits immunized with KLH alone, and "Test" 
is the number of parasites which invaded 1,000 erythrocytes in the presence 
of serum from rabbits immunized with EBA-peptide 4 conjugated to KLH. 
Results 
Evaluation of Gene Fragment Identified 
by AJfinity-purified Monospecific Antibodies 
against EBAo175 
Preparations of EBA-175 (Camus and Hadley, 1985; Orlandi 
et al.,  1990) were used to obtain affinity-purified monospe- 
cific polyclonal antibodies against EBA-175 (Orlandi et al., 
1990)  and  subsequently used to  identify the  initial  clone 
(EBA1.8/Y1090)  from the  library.  This clone contained a 
1.8-kb insert which when subcloned into the expression vec- 
tor Y1089 expressed a beta-galactosidase fusion protein that 
was  recognized in immunoblot analysis by the affinity-pu- 
rified antibodies to EBA-175. The fusion protein was unsta- 
ble and rapidly degraded to a 65-kD protein (Fig. 1 A). Both 
the  65-kD  expressed protein and  nitrocellulose filter lifts 
Figure L  Evaluation ofa 1.8-kb gene fragment identified by affinity- 
purified monospecific antibodies against EBA-175 by immunoblot 
analysis.  (A) Blots were probed with antibodies against EBA-175 
affinity purified from immune monkey serum using purified EBA- 
175 as the affinity substrate as described in Materials and Methods. 
Immunoblot of purified  EBA-175  as  described  in Materials  and 
Methods (lane 1); proteins from EBA1.8/Y1089 grown with IPTG 
to  induce  beta-galactosidase  (lane  2);  or  EBA1.8/Y1089  grown 
without IPTG (lane 3).  The expressed protein was rapidly broken 
down from being fused to beta-galactosidase (total size ,o120 kD) 
into a 65-kD fragment of expressed protein without beta-galactosi- 
dase.  (B) Immunoblot of total parasite culture supematant anti- 
gens. Strips were probed with: total immune monkey serum (lane 
1), antibodies against EBA-175 affinity purified from immune mon- 
key serum (lane 2), antibodies selected from immune monkey se- 
rum by affinity-purification with the 65-kD expression protein (lane 
3),  antibodies  selected  from  immune monkey  serum by  affinity 
purification with filter lifts of confluent plaques of EBA1.8/Y1089 
(lane 4),  or normal monkey serum (lane 5). 
from confluent plates of clone EBA1.8/Y1090  were used to 
affinity purify antibodies from immune monkey serum con- 
taining  antibodies  against  EBA-175. Such  affinity-purified 
antibodies recognized the authentic EBA-175 in immunoblots 
(Fig.  1 B). 
Nucleotide and Deduced Amino Acid Sequence of 
EBA-175 Gene 
The 1.8-kb insert contained a 1.7-kb-long open reading frame 
that is in-frame with beta-galactosidase, followed by a highly 
AT-rich region with multiple stop codons at the 3' end. The 
1.8-kb insert was used as a probe to isolate a 5.5-kb Xba I 
fragment that contained an additional 2.2-kb open reading 
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1  ATGAAATGTAATATTAGTATATATTTTTTT 
N  V  Q  K  T  D  K  K  I  F 
151  AATGT  TCAAAAAACTGATAAGAAAATATTT 
E  E  M  F  N  N  N  ,Y  o  S 
301  GAAGAAAT  GT  TTAACAACAAT TATCAATCA 
N  M  E  V  l  $  N  C  R  E 
451  AATAACGAAGT  TTTAAGTAAT TGTAOGGAA 
K  E  T  M  K  D  H  F  ]  E 
601  AAAGAGACCATGAAGGATCATTTCATTGAA 
M  D  F  G  G  Y  S  T  K  A 
751  ATGGATTT  TGGAGGT TATT CAACTAAGGCA 
S  E  H  K  N  N  I  N  N  C 
901  TCT OAGCATAAAAATAATATAAATAAT  TGT 
L  Y  E  A  C  E  K  E  C  I 
1051  T  TATAT  GAAGCAT  GT  GAGAAGGAATGTATT 
I  $  E  N  K  N  D  A  K  V 
1201  AT T  T  CAGAAAACAAOAATGATGCTAAAGTA 
H  I  D  L  D  D  F  S  K  F 
1351  CATATTGATTTAGATGATTTTTCTAAATTT 
I  D  R  I  Y  D  K  N  L  L 
1501  AT T  GATAGAATATACGATAAAAACCTATTA 
R  D  l  I  G  0  T  D  Y  W 
1651  AGAGATAT  TATAGGAGGTACTGAT  TAT TGG 
V  W  N  V  I  $  W  V  F  K 
1801  GTATGGAATGTGATATCATGGGTATTCAAG 
E  C  K  E  K  P  C  E  D  D 
1951  GAAT  OCAAAGAAAAACCT  TGTGAAGAT  GAC 
E  F  K  S  I  K  P  E  V  Y 
2101  GAATT  TAAAT  CTATAAAACCAG/~GTTTAT 
S  I  I  R  N  N  E  Q  T  S 
2251  TCTATAATAAGAAATAATGAACAAACTTCG 
S  V  S  P  E  N  S  R  P  E 
2401  AGTGTATCACCAGAAAATTCAAGACCTGAA 
N  ]  S  G  V  N  S  K  P  L 
2551  AATATT  T  CCGGGGTGAATTCTAAACCTTTA 
$  G  S  A  T  V  S  E  S  S 
2701  AGTGGAAGT  GCAACAGTGAGTGAATCTAGT 
E  K  G  A  D  E  E  R  H  S 
2851  GAAAAAGGCGCAOATGAAGAAAGACATAGT 
G  G  I  V  N  M  N  V  E  K 
3001  GGAGGAAT  TGTTAATATGAATGTTGAGAAA 
D  N  T  S  E  E  T  T  E  R 
3151  GA  T  AACACCAGT GAAGAAAC  TACACd~AAGA 
0  E  N  S  0  L  S  T  V  N 
3301  GACGAAAAT  TCAOACTTATCTACTGT/L~AT 
L  G  T  T  H  V  Q  N  E  [ 
3451  T  T  GGGAAC  CACACAT GTACAA/L~CGAAAT T 
R  N  S  N  T  L  H  L  K  D 
3601  AGAAATAGTAATACATTACATTTA~AGAT 
E  R  $  Q  I  N  H  $  H  H 
3751  GAAAGAAGT  CAAAT TAATCAT AGTCATCAT 
L  Y  E  N  R  N  D  S  T  T 
3901  C  T  T  TAT GAAAACAGAAAT GATAGTACAACJ~ 
R  N  L  C  C  A  V  S  D  Y 
4051  AGA~TCTGTGT TGTGCAGTATCAGATTAC 
L  !  T  N  K  !  Y  Y  Y  F 
4201  T  TAATAAC~TAAAATATATTATTATTTT 
4351  TGG  T  TAT T  T  T  AGGT  G  CT TCACAA~CCADJ~T 
ASFFVLYFAK 
GCTTCCTTCTTTGTGTTATATTT~CAAK~ 
TFIENKLDIL 
ACTTTTATAGA~T~TTAGATATTTTA 
FLSTSSLIKQ 
TTTTTATCGAC~GTTCATTAATA~GCAA 
KRKGMKWDCK 
~AAGGAAAGGAATGAAATGGGATTGTAAA 
ASKKESQLLL 
GCCTCTAAAAAAGAATCTCAACTTTTGCTT 
ENKIQEVFKG 
GAAAACAAAATTCAAGAAGTTTTT~AGGG 
KNIPQEELQI 
AAAAATATTCCCCAAG~G~TTACAAATT 
DPCMKYRDWI 
GATCCATGTATGAAATATA~GATTGGATT 
~LLLNNCDAE 
AGTTTATTATTG~T~TTGTGATGCTGAA 
GCDKNSVDTN 
GGATGTGATA~ATTCCGTTGATACA~C 
MIKEHILAIA 
ATGATAAAAGAGCATATTCTTGCTATTGCA 
NDLSNRKLVG 
AATGATTTGAGCAATAGA~TTAGTAGGA 
DKTVCKEDDI 
GATAAAACTGTTTGTA~GATGATATT 
NCKSKCNSYK 
AATTGT~AAGTAAATGT~TTCATAT~A 
LKKYSEKCSN 
TT~AG~ATACTCGGAA/U~ATGTTCT~C 
~EAVPEENTE 
CAAG~GCAGTTCCTGAGGAAAACACTG~ 
TDAKDT$NLL 
ACTGATGCTAAAGATACTTCTAACTTGTTA 
$ODVRPDKKE 
TCTGATGATGTACGTCCAGATAAA/~kGGAA 
$SNTGLSIDD 
AGTTCAAATACTGGATTGTCTATTGATGAT 
TSESLSSPEE 
ACTTCTGAAAGCTTAAGTTCACCTGAAG~ 
ELKDTLENPS 
GAACTA~A~TACTTTACdUUU4TCCTTCT 
ISNNEYKVNE 
ATTAGT~TAATG~TAT~OTT~C~G 
DESEDAEAKM 
GATG~TCAG~GACGCT~GC~TG 
SVPVTGEIDE 
AGTGTTCCTGTTACAG~G~TT~T~A 
IRNEENERHL 
AT~T~GGAJULACGAAAGACACTTA 
GNRQDRGGM$ 
GGAAACAGA~TCGGGG~GAAATTCT 
KELIKKLAE! 
~G~TT~T~G~TTAGCA~ATA 
CMSYFTYDSE 
TGTATGAGCTATTTTACATAT~TTCAGAG 
YTYKTAKVT! 
TATACTTACAAAACTGCAAAAGT~CAATA 
ATCAAAGGTTAGAAJUU~TAAATAAAAATA 
A  R  N  E  Y  D  I  K  E  N 
GCTAGG/U~T  G/~TAT GATAT/L~kAGAGAAT 
N  N  S  K  F  N  K  R  W  K 
AATAAT T  CAAIU~T  T  TAATAAAACd~TGG/L~G 
N  K  Y  V  P  I  N  A  V  R 
AATAAAT AT GTT  CCTATT/U~CGCTGTACGT 
K  K  N  D  R  S  N  Y  V  C 
AAGAAAAATCd~TAGAAGCA&CTAT GTATGT 
K  K  N  0  N  K  Y  N  S  K 
AAAIU~/U~T GATAACA~J~TATAATTCT/UU~ 
A  H  G  E  I  S  E  H  K  I 
GCTCATGGGGAAATAAGT  GAACATA/~kATT 
T  Q  W  I  K  E  W  H  G  E 
ACT  C~&T GGATAKAAGAATGGCATGCd~GAA 
I  R  S  K  F  E  W  H  T  L 
AT TAGAAGTAK~TT T  GAAT  GGCATACGT  TA 
Y  S  K  Y  C  D  C  K  H  T 
TAT T  CAA/L~TAT T  GTGAT  TGTA~d~CJ~TACT 
T  K  V  W  E  C  K  N  P  Y 
ACAAAGGTGTGGGAAT  GT/L~ADJ~CCCTTAT 
]  Y  E  S  R  I  L  K  R  K 
A  T  A  T  AT  GAAT  CA  AG/L~T  AT  T  GA/L~C  G/L~ 
K  I  N  T  N  S  K  Y  V  H 
AAKAT T/U~CACAAAT TCAAJ~TAT GTTCJ~C 
E  N  !  P  Q  F  F  R  W  F 
GAAAATATACCACAATTCTTCAGAT GGTTT 
E  W  1  S  K  K  K  E  E  Y 
GAATGGATAT CAAAAAAAAAAGAAGAGTAT 
L  N  F  E  D  E  F  K  E  E 
CT AAAT T  T  CGAAGAT  GAAT  TTAAGGAAGAA 
]  A  H  R  T  E  T  P  S  1 
ATAGCACACAGAACGGAAACT  CCATCTATC 
K  L  K  G  D  V  D  I  S  M 
AAAT TA/LkAGGAGAT  GTTGATAT TAGTAT G 
L  E  D  Q  N  S  D  E  S  E 
T  TAGAAGAT  CAAAATAGTGAT G/U~TCGGAA 
D  R  N  G  D  T  F  V  R  T 
GAT  AGAAAT  GG  T  GATACAT T  T  GT  T  CG/~kCA 
K  M  L  T  D  )4  E  G  G  N 
AAAATGT TAACT GAT/~T GAAGGAGGAK~T 
S  S  L  D  E  G  K  A  H  E 
AGTAGCT TGGATGK~GGA/~GCACATCd~ 
R  E  D  E  R  T  L  T  K  E 
AGGGAAGAT  GAGAGAACGCTTACT/U~GGAA 
K  G  N  D  T  S  E  M  S  H 
AAAGGAAAT GATACAT CTGA~U~TGT  CGCAT 
K  L  R  E  S  K  E  S  K  ! 
AAAT TAAGGGAAAGTAAAGAATCAAAAAT T 
T  N  Q  N  I  N  I  S  Q  E 
ACTAAT CAAAACATTAATATTAGTCAAGAA 
G  N  V  L  N  M  R  S  N  M 
GGGAATGT  TTTAAATATGAGATCTAATAAT 
N  K  C  E  N  E  I  S  V  K 
AATA~J~T GTGAGAACGA/~kT  T  TCTGTA~J~A 
E  Y  Y  N  C  T  K  R  E  F 
GAATAT TATAAT TGTACGAAAAGGGAAT T  T 
K  K  !  N  F  S  L  !  F  F 
AAAAAAATTAATTTCTCATTAATTTTTTTT 
AAAT TGAGAAGAAT  G  TAAATTAAATATAGA 
TATATATATATATATATATAGATAA 
E  K  F  L  D  V  Y  K  E  K 
GAAA~JkT  T  T  TTA~CGT GTAT~GAAA~J~ 
S  Y  G  T  P  D  N  I  O  K 
AGTTAT GGAACT  CCAGATAATATAGAT/UU~ 
V  8  R  1  L  $  F  L  D  S 
GTGTCTAGGATATTAAGTTTCCTGGATTCT 
I  P  D  R  R  I  Q  L  C  I 
ATTCCTCd~TCGTAGAAT CC/L~T  TATG CATT 
F  C  N  D  L  K  N  S  F  L 
TTT TGTN~TGAT TTG/L~G/L~TAGT  TT T  TTA 
K  N  F  R  K  E  W  W  N  E 
AAJ~/U~T  T  T  TAG/L~AA~T GGTGGAATG/U~ 
F  L  L  E  R  D  N  R  S  K 
TT T  TTGCTTG/L~AGAGAT/U~TAGATCAAAA 
S  K  E  Y  E  T.g  K  V  P 
T  CGAAAGAATATGA/~CT CAAAAAGTT CCA 
T  T  L  V  K  S  V  L  N  G 
ACTACTCTCGTTAAAAGCGT T  T  TA/LkTGGT 
1  L  $  T  K  D  V  C  V  P 
ATATTATCCACTAAAGAT GTATGT  GTACCT 
Y  K  N  K  D  D  K  E  V  C 
TATAAGAATAAAGAT GATAAAGAAGT TTGT 
R  N  K  K  N  D  K  L  F  R 
AGGAATA/~ZAkAAAT  GATAAGCT  T  T  TT CGT 
S  E  W  G  D  D  Y  C  0  D 
AGTGAATGGGGT  GATGATTAT T  GCCAGGAT 
W  K  g  A  K  Q  Y  Q  E  Y 
AATAAACAAGCCAAACAATACCAAGAATAT 
L  H  S  0  Y  K  N  K  C  T 
TTACATTCAGATTATAAAAATA/U~TGTACG 
S  E  G  P  K  G  N  E  Q  K 
T  CTGAAGGACCAAAAGGAAAT  GAAC.AAAAA 
P  K  A  V  I  G  S  S  P  N 
CCTAAAGCAGT TATTGGGAGCAGT  CCTAAT 
E  T  V  V  N  H  !  S  K  S 
GA/~CTGTAGTAAATCATATAT CAAAAAGT 
Q  D  T  A  N  T  E  D  V  1 
C/~kGATACAGCAAATACTGAAGATGT  T  AT T 
S  L  N  H  E  E  V  K  E  H 
AGT  TTAAAT CAT  GAAGAGGTGAAAGAACAT 
E  L  S  E  P  N  L  S  S  O 
GAAT  TATCAGAACCAAATCTAAGCAGTGAC 
Y  E  D  l  V  L  K  S  H  M 
TAT GKkCd~TATTGT  TTT GK~ULkGT  CATATG 
N  S  S  Q  H  I  E  S  D  Q 
AATAGTAGTCAACATATTGAGAGTGATCAA 
H  K  A  E  E  E  R  L  S  H 
CATAAGGCTGAAGAGGAAAGAT  TAAGT CAT 
R  D  L  Q  K  H  G  F  H  T 
AGGGATTTGCAAAAACAT GGATTCCATACC 
N  N  F  N  M  ]  P  S  R  Y 
AATAAT TTTAATAATAT TCCAAGTAGATAT 
Y  C  D  H  M  I  H  E  E  I 
TATTGTGACCATATGATTCAT GAAGAAATC 
D  O  P  S  Y  T  C  F  R  K 
GAT  GATCCATCT TATACATGT TTCAGAAAG 
F  F  F  S  F  * 
TTCTTTTTTTCTTTTTAGGTATGCCATATT 
ATTCGAGCTCGG 
T~CATATA~TATATTC~TGTGCATAQA 
FNELDKKKYG50 
TTT~TG~TTAGATA~GAAATATGGA 
NMSLINKHNNIO0 
~TATGTCTTT~TA~TAAACATAATAAT 
RINNGRNTS$150 
AG~TT~TAATGGAAGAAATACTTCATCT 
VNLSIIKTYT200 
GTT~TCTTAGCATTATTA~ACATATACA 
DYGHLAMGND250 
GATTATGGACATCTTGCTATGGGAAATGAT 
FREKLWEAML300 
TTTAGAGAGAAACTTTGGGAAGCTATGTTA 
LPKSKCKNNT350 
TTGCCAA~AGTA~TGT~AAAT~TACA 
KENAENYLIK400 
~GGAAAATGCGGAAAATTATTTAATCAAA 
NDNTIKEKRE450 
AACGACAATACAATTAAGGANL~GCGTGAA 
PRRQELCLGN500 
CCGAGGAGGCAAGAATTATGTCTTGGAAAC 
KIINKTFADI550 
/UULATCATAAATA~ACTTTCGCTGATATA 
DEWWKVIKKD600 
~T~GTGGTGGAAAGTTATT~A~AGAT 
KTKMIETLKV650 
A~CAAKAATGATAGAGACTCTG~GGTT 
QKGNNYKMYST00 
~AAAAGGAAATAATTAC~TGTATTCT 
M  C  P  E  V  K  0  V  P  I  ~0 
ATGTGTCCAGAAGT~AGGATGTACCAATT 
ERDDDSLSKI800 
GAACGTGATGACGATAGTTTGAGT~AATA 
DNINVTEQGD850 
~T~TATAAATGTTACT~AC~GGGGAT 
PSINNGDDSGgO0 
CCATCTATA~T~TGGA~TGATTCAGGC 
R  K  E  N  A  D  K  D  E  D  950 
AGAMUkG~TGCTGACAAGGATGAAGAT 
TSNSDNVQQS1000 
ACTAGT~TTCTGAT~TGTTC~CAGTCT 
QDMSNTPGPL1050 
C~TATGTCTAATACACCTGGACCTTTG 
NR~SDDGELYllO0 
~TA~GAATCAGACGATGGT~ATTATAT 
QKNDMKTVGD1150 
~GA/~CGATATGAAAJ~CTGTTGGTGAT 
TDIHKINPED1200 
A~TATA~TAA/L~TT~TCCTG~GAT 
MNNLHGDGVS1250 
ATGAAT~TCTACATGGAGATGGAGTTTCC 
NLYDKKLDLD1300 
~TTTATAT~TAAMUU~TTAGATTTAGAT 
PLKTCTKEKT1350 
CCATTAA/U~kCATGCACTAK~CA 
EAFSSMIFKF1400 
~GGCTTTTTC~GTATGATATTCAP&TTT 
1435 
ATG~GGAGCAGGTGTGTTATTTATTATAT 
Figure 2.  Structure of the gene encoding  EBA-175 from the Camp strain of P. falciparum. (A) Representation of the overlapping clones 
sequenced.  The restriction sites shown are D  (Dde I),  E (Eco RI), H (Hind HI), and X (Xba I). Cross-hatched area represents coding 
region. (B) Nucleotide and deduced amino acid sequences of EBA-175. Nucleotides are numbered on the left and amino acids are numbered 
on the right. EBA-peptide 4  (residues  1,062-1,103)  is underlined.  The hydrophobic amino-terminal signal sequence is also underlined. 
These sequence data are available from EMBL/GenBank/DDBJ  under accession number X52524. 
frame (Fig. 2 A). Further upstream sequences were obtained 
from clones 2.5 and 3.5 kb. The sequences obtained coded 
for a total of 1,435 amino acid residues (Fig, 2 B). The signal 
sequence spans residues  1-19.  The deduced amino acid se- 
quence showed that EBA-175  is a highly charged molecule 
with  uneven  charge  distribution.  At  physiologic  pH,  the 
NH2-terminal portion of the molecule is positively charged 
(the calculated pl of residues 1-600 is 9.50), the region from 
amino  acid  residues  601-1,200  is  negatively  charged  (pI 
4.23), and the COOH-terminal portion (1,201-1,435) is again 
positively charged (pl 8.08). 
The  gene  encoding  EBA-175  is  unique  when  compared 
with other characterized malaria antigens (Devereux et al., 
1984) and does not contain repetitive sequences as are com- 
monly found in malarial genes.  However, there are two re- 
gions encompassing '~190 amino acid residues each (179- 
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noblot and immunoprecipitation analyses using antibodies against 
EBA-peptide 4. (A)Immunoblots of total parasite culture superna- 
tant antigens (lanes I and 2) or purified EBA-175 (lanes 3 and 4). 
These strips were probed with antibodies selected from immune 
monkey serum by affinity purification with purified EBA-175 (lanes 
1 and 3), or with mouse antibodies against EBA peptide 4 (lanes 
2 and 4).  (B) Fluorography of 3H-isoleucine-labeled total para- 
site culture supernatant antigens (lane 1), purified EBA-175 prepa- 
ration  from 3H-isoleucine-labeled parasite  culture  supernatants 
(lane 2), antigens from labeled culture supernatants immunoprecip- 
itated  by mouse  antibodies against EBA-peptide 4  (lane 3),  or 
purified EBA-175  from labeled culture supernatants immunoprecip- 
itated by mouse antibodies against EBA-peptide  4 (lane 4), showing 
that antibodies raised against the synthetic EBA-peptide 4 recog- 
nized authentic EBA-175. Similar results were obtained when rabbit 
antipeptide 4 antibody was used in immunoblots (as in A) and in 
immunoprecipitation experiments (as in B). 
370 [VCIP-RDWI] and 487-673 [VCVP-KEWI]) that have 
similar spacings for eight cysteine and six tryptophan resi- 
dues each. 
The deduced amino acid sequence of  the EBA-175 gene en- 
codes a protein with many predicted antigenic sites (Hopp 
and Woods, 1981). Three predicted antigenic peptides, EBA- 
peptide 2 (residues 939-969), EBA-peptide 5 (residues 970- 
1,014), and EBA-peptide 4 (residues 1,062-1,103),  were syn- 
thesized based on these predictions and used to immunize 
mice and rabbits. 
Antibodies against Synthetic 
Peptides, Immunoblotting, and 
Immunoprecipitation Analysis 
ELISA antibody titers  of immune  sera  titered against the 
respective unconjugated peptides, defined as the highest di- 
lution giving an absorbance greater than two standard devia- 
tions above the mean absorbance for control sera from mice 
or rabbits immunized with KLH alone, were >1:50,000 for 
the  three  peptides  tested.  Only  antibodies  against  EBA- 
peptide 4 raised in mice or rabbits identified EBA-175 in im- 
munoblots of total parasite culture supernatant antigens, or 
in blots of purified EBA-175 preparations (Fig. 3 A). These 
same antibodies against EBA-peptide 4 precipitated EBA-175 
from culture supernatants and preparations of purified EBA- 
175 (Fig. 3 B). Antibodies raised against EBA-peptide 2 or 
EBA-peptide 5 conjugated to KLH did not recognize malar- 
ial antigens in immunoblots or in immunofluorescence as- 
says (data not shown). Controls for these experiments, per- 
formed with antibodies raised against the carrier KLH, were 
all negative. 
Immunofluorescent Localization of  EBA-175 
In the immunofluorescent antibody test using sera from mice 
and rabbits immunized with EBA-peptide 4  conjugated to 
KLH, the fluorescence pattern showed staining throughout 
the cytoplasm of merozoites in schizonts with more intense 
staining near the apical end oriented away from the central 
pigment body (Fig. 4). These same antibodies stained free 
merozoites but did not stain ring-stage parasites. Two color 
immunofluorescence reactivities of antibodies against EBA- 
peptide 4  conjugated to KLH and mAb 3B10.1 against the 
merozoite surface antigen gp195,  showed the difference be- 
tween the staining patterns of these antigens.  EBA-175 was 
localized and appeared as a dot, while in contrast, gp195 was 
on the surface of the entire merozoite (shown in black and 
white in Fig. 4). Antibodies raised against the carrier mole- 
cule KLH alone did not react with malaria parasites (data not 
shown). 
Blocking of  EBA-175 Binding to Erythrocytes by 
EBA-peptide 4 Antibodies 
To investigate the functional relevance of antibodies raised 
against EBA-peptide 4,  we incubated serum from a  rabbit 
immunized with EBA-peptide 4 conjugated to KLH with cul- 
ture supernatants containing EBA-175, and determined the 
capacity of this treated EBA-175 to bind to erythrocytes. In- 
hibition of binding of EBA-175 to erythrocytes was depen- 
dent on  the  concentration of serum  raised  against  EBA- 
peptide 4 that was used; the inhibitory activity was 92% at 
a  1:5 dilution of the serum (Fig. 5, lane 4). This inhibition 
was not seen with control serum from a rabbit that had been 
immunized with KLH alone (Fig. 5,  lanes 5-7). 
Inhibition of  Merozoite Invasion of  Erythrocytes 
We further investigated the effect on the parasite of antibod- 
ies against EBA-peptide 4  in an in vitro invasion inhibition 
assay.  Similar to its inhibition of the binding of EBA-175 to 
erythrocytes, serum raised against EBA-peptide 4 inhibited 
merozoite invasion in a dose-dependent manner (Fig. 6); the 
inhibitory activity was 80% at a 1:5 dilution of serum. Inhi- 
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stage P falciparura parasites 
of  antibodies against EBA-pep- 
tide 4 and an mAb against the 
major merozoite surface anti- 
gen gp195 (3B10.1)  by two col- 
or  immunofluorescence pre- 
sented  in  black  and  white. 
Vertical columns from left to 
right show phase-contrast re- 
activity with antibody 3B10.1 
and reactivity with 1:1,000 di- 
luted mouse anti-EBA-peptide 
4 sera, respectively. Horizon- 
tal columns show  various  blood 
stages of P falciparum. Ar- 
row locates a merozoite (d), 
and a ring-stage parasite  (g). 
Antibodies to EBA-peptide 4 
stained  the  merozoite  cyto- 
plasm with more intense stain- 
ing at the apical end (c and  f). 
Magnification, 1000x. 
bition was not seen with control serum from a rabbit that had 
been immunized with KLH alone. 
Abrogation of  Activity of  Immune Sera 
To clearly demonstrate that this activity was mediated by an- 
tibodies specific for EBA-peptide 4, we preincubated the sera 
from immunized animals with either EBA peptide 4 or with 
an unrelated peptide of similar size, and repeated the binding 
and invasion experiments shown in Figs. 5 and 6. Preincuba- 
tion of immune sera with EBA peptide 4  (20 #g/ml) com- 
pletely eliminated the capacity of the immune sera to block 
binding of EBA-175 to erythrocytes, and to inhibit merozoite 
invasion of erythrocytes. Preincubation with the unrelated 
peptide had no effect (data not shown). 
Discussion 
Since the binding of EBA-175 to intact erythrocytes corre- 
lates with the capacity of merozoites to invade these erythro- 
cytes, and EBA-175 binds to merozoites (Camus and Hadley, 
1985), it was postulated that EBA-175 may be a receptor act- 
ing as a "bridge" between erythrocytes and merozoites. We 
hypothesized that  antibodies  against  this  molecule would 
therefore inhibit  the  invasion of merozoites into  erythro- 
cytes, and that regions of EBA-175 would be potential vac- 
cine candidates. In this report we describe the cloning and 
characterization of the gene encoding EBA-175,  and show 
that sera from animals immunized with a synthetic peptide 
(EBA-peptide 4) comprising amino acid residues 1,062-1,103 
block the binding of  EBA-175 to erythrocytes  and also inhibit 
parasite invasion in vitro. These results suggest that the anti- 
bodies induced by immunization with EBA-peptide 4 inhibit 
invasion by inhibiting binding of EBA-175 to erythrocytes. 
This activity is  mediated by antibodies  specific for EBA- 
peptide 4,  since preincubation of anti-EBA-peptide 4  anti- 
sera with EBA-peptide 4 completely eliminated the capacity 
of the immune sera to mediate both these activities. 
Binding of EBA-175 to erythrocytes involves sialic acid 
(Camus and Hadley, 1985). However, the molecular details 
of the interactions between merozoite, EBA-175, and eryth- 
rocyte have not been elucidated.  Analysis of the deduced 
amino acid sequence of the gene encoding EBA-175 has led 
us to propose possible models for this process. The EBA-175 
molecule is highly charged with uneven charge distribution. 
At physiologic pH, the NH2-terminal portion of the mole- 
cule  is  positively  charged  (the  calculated  pI  of residues 
1-600  is 9.50)  and the rest of the molecule is  negatively 
charged (pI of residues 601-1,200 is 4.23) except the COOH- 
terminal end (residues 1,201-1,435)  where it becomes posi- 
tively charged again with a calculated pI of 8.08. Initial con- 
tact of the EBA-175 molecule with negatively charged sialic 
acids on erythrocytes could occur at the positively charged 
terminal portions of EBA-175. However, charge may not be 
the only factor important for binding to erythrocytes. There 
are similarities between the contact amino acid residues of 
the siaiic acid binding site of an influenza virus hemaggluti- 
nin (Weis et al.,  1988) and residues in EBA-175, occurring 
mainly within the negatively charged region of EBA-175, in- 
cluding  EBA-peptide 4.  Perhaps  antibodies  against  EBA- 
peptide  4  interfere with  an  essential  binding  function of 
EBA-175 that involves sialic acid, and thereby inhibit mero- 
zoite invasion of erythrocytes. 
Several P. falciparum proteins including rhoptry proteins 
(Sam-Yellowe and Perkins,  1990),  155- and  130-kD glyco- 
phorin binding proteins (Perkins, 1984), 140-, 70-, and 35- 
kD (Jungery et al.,  1983) glycophorin binding proteins, and 
the 200-kD major merozoite surface antigen (Pf200 or gp195) 
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Figure 5. Blocking of EBA-175 binding to erythrocytes in vitro by 
antibodies against EBA-peptide  4. Lane 1 shows an autoradiograph 
of EBA-175 binding to erythroeytes in the absence of rabbit serum, 
showing EBA-175  binding under normal conditions. Lanes 2-4 de- 
pict binding in the presence of 1:20, 1:10, and 1:5 dilutions of rabbit 
anti-EBA-peptide  4 sera, respectively, showing decreasing amounts 
of  EBA-175  bound to erythrocytes in the presence of  increasing con- 
centrations of serum. Lanes 5-7 show binding in the presence of 
1:20,  1:10, and  1:5  dilutions  of rabbit  anti-KLH  control  sera, 
respectively. EBA-175 binding to erythrocy~ was quantitated by 
scanning densitometry of the autoradiographs (LKB 2022 Ultra- 
scan laser densitometer). Blocking of EBA-175 binding to erythro- 
cytes in the presence of serum raised against EBA-peptide  4 is ex- 
pressed as percentage blocking of EBA-175 bound to erythrocytes 
relative to the accompanying anti-KLH control. Values are as fol- 
lows: 1:20 (23% blocking),  1:10 (85% blocking), and  1:5 (92% 
blocking). 
(Perkins and Rocco, 1988) have also been proposed to be in- 
volved in erythrocyte invasion.  Our  findings demonstrate 
that the primary structure of EBA-175 is distinct from these 
proteins, as well as unique when compared to other malarial 
proteins. In contrast to most Plasmodium sp. genes that have 
been reported, the EBA-175 gene does not encode repeated 
amiiao  acid  sequences.  However, analysis of the primary 
structure of EBA-175 shows that there is a "repeated" motif 
between regions comprising amino acid residues  179-370 
and 487-673 in that these regions have similar spacings for 
eight cysteine and  six tryptophan residues each.  There is 
only limited similarity between the other residues, hydrophi- 
licity profiles,  and  predicted  secondary structures  within 
these two regions; however, these regions may represent two 
domains diverging from a primitive gene that was duplicated 
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Figure 6. Inhibition of  merozoite invasion into erythrocytes in vitro 
by rabbit serum against EBA-peptide 4 performed as described in 
Materials and Methods. Data are graphically expressed as the per- 
cent inhibition of merozoite invasion, calculated as described in 
Materials and Methods. The number of infected erythrocytes per 
100 erythrocytes was significantly lower (P < 0.005, t test) in the 
erythrocytes exposed to anti-EBA-peptide  4 sera as compared to the 
control anti-KLH sera at serum dilutions of 1:5 (2.3 + 0.33 vs 13.7 
+  0.33, mean +  SEM percentage of infected erythrocy~s), 1:10 
(4.3 +  1.20  vs 13.7 -I- 0.33), and 1:20 (8.3 -t- 0.33 vs 14.0 + 0.33). 
Inhibition of invasion was also seen in three separate experiments 
performed in triplicate with mouse anti-EBA-peptide 4 sera (data 
not shown). 
some time in the distant past. The function of this cysteine 
and tryptophan residue "repeat" pattern is unknown. 
The potential importance of EBA-peptide 4  as a vaccine 
candidate is also supported by the observation that this pep- 
tide is conserved at the nucleic acid level in seven strains of 
P. falciparum studied from different parts of the world (Sim, 
1990).  Furthermore,  the  structure  of the  EBA-175  gene 
among several strains of P. falciparum from different parts 
of  the world appeared to be conserved when fragments of  the 
EBA-175 gene from the Camp strain were hybridized to re- 
striction endonuclease-digested genomic DNA from other 
strains. In genomic Southern blot analyses with restriction 
enzymes Eco RI, Dde I, Xba I, and Hind III, the 1.8-kb frag- 
ment and the 5' Xba I-Hind IR fragment (Fig.  1 A) showed 
strong  hybridization to  DNA  from  P. falciparum  strains 
Camp (Malaysian), FCR3 (Gambia), and 7G8 (Brazil), plus 
isolates  from St.  Lucia,  Brazil,  and  Honduras  (data  not 
•  shown). In addition, the sizes of restriction fragments recog- 
nized were virtually identical except for the FCR3  strain, 
which  showed  restriction  fragment  length  polymorphism 
with restriction enzymes Dde I and Hind IR. This indicates 
that there is  a  high  degree of homology among different 
strains in regard to the gene structure and supports the obser- 
vation that EBA-175 is antigenically conserved (Orlandi et 
al.,  1990). 
The putative merozoite receptor EBA-175  thus  appears 
conserved among the P. falciparum strains studied. With the 
demonstration that antibodies to EBA-peptide 4, an invariant 
Sim et al. Erythrocyte Binding Antigen of P. falciparum  1883 region of the molecule, block the binding of EBA-175 to 
erythrocytes and also inhibit merozoite invasion of erythro- 
cytes, EBA-peptide 4 is clearly identified as a malaria vac- 
cine candidate. 
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